Disease Remission is Achieved Within Two Years In Over Half of Methotrexate Naive Patients with Early Erosive Rheumatoid Arthritis (RA) Treated with Abatacept Plus MTX: Results from The AGREE Trial

Haraoui, Boulos;Durez, Patrick;Westhovens, Rene;Robles, Manuel;Helfrick, Roy;et.al.
(2010) 65th Annual Meeting of the Canadian-Rheumatology-Association — Location: Quebec (Canada) (3.February.2010)

Files

No attached file found for this publication.

Details

Authors
  • Haraoui, Boulos
    Author
  • Author
  • Westhovens, ReneUCLouvain
    Author
  • Robles, Manuel
    Author
  • Helfrick, Roy
    Author
Show more
Affiliations

Citations

Haraoui, B., Durez, P., Westhovens, R., Robles, M., Nayiager, S., Wollenhaupt, J., Gomez-Reino, J., Grassi, W., Shergy, W., Park, S.-H., Genant, H., Peterfy, C., Becker, J.-C., Covucci, A., Bathon, J., & Helfrick, R. (2010). Disease Remission is Achieved Within Two Years In Over Half of Methotrexate Naive Patients with Early Erosive Rheumatoid Arthritis (RA) Treated with Abatacept Plus MTX: Results from The AGREE Trial. Journal of Rheumatology, 37(6), 1287-1288. https://hdl.handle.net/2078.5/146973 (Original work published 2010)